Self-Assessment Credits

The Post-test must be completed by you within 10 days after the conclusion of the MSS Annual Meeting. You must obtain a performance level off at least 75% on the Self-Assessment post-test. If you do not achieve 75% you can re-take the post-test in order to receive Self-Assessment credit. You must complete the SA Post-Test by Tuesday, May 14, 2024.

Question Title

* Your Name

Question Title

* Choose One

Question Title

* 11:00am-11:30am | Cancer Update
2024 Colon Cancer Update
Wolfgang Gaertner, MD, FACS
Colon cancer is predicted to become the number one cause of cancer-related death by 2023 in which patient population?

Question Title

* 11:00am-11:30am | Cancer Update
2024 Colon Cancer Update
Wolfgang Gaertner, MD, FACS
A 55-year-old woman is recently diagnosed with colon cancer on routine screening colonoscopy. What imaging studies should be performed for initial staging purposes?

Question Title

* 11:00am-11:30am | Cancer Update
2024 Colon Cancer Update
Wolfgang Gaertner, MD, FACS
A 40-year-old woman, whose 48-year-old brother was recently diagnosed with colon cancer, underwent a screening colonoscopy and had normal findings. What is the most appropriate timing for repeat colonoscopy?

Question Title

* 11:30am-12:00pm | Cancer Update
Axillary Management Updates in Breast Cancer Patients
Mary Mrdutt, MD, FACS
A 55 year old female returns to your clinic for surgical planning. She was diagnosed with a cT2N1 grade 3 triple negative invasive ductal carcinoma of her right breast after self palpating a mass. A suspicious right axillary lymph node was biopsied and found to be involved. She was treated with neoadjuvant therapy according to the Keynote 522 regimen with excellent clinical and radiologic response in the breast and axilla. Which of the following would NOT be an acceptable approach to axillary surgery for this patient?

Question Title

* 11:30am-12:00pm | Cancer Update
Axillary Management Updates in Breast Cancer Patients
Mary Mrdutt, MD, FACS
Taking into account Choosing Wisely Guidelines and the recent SOUND trial publication, which of the following patients would it be safe to recommend omitting axillary staging at time of lumpectomy for an invasive carcinoma?

T